HealthQuill Health
AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival
Health Research

Research reveals first child after age 30 increases breast cancer risk by over 40%

HQ Team August 18, 2025: Research finds that women who have their first child after age 30 face a 40% to 45% higher.

Read More
The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.
Drugs Health

Implant TAR-200 eliminates bladder cancer in over 80% of high-risk cases in trials

HQ Team August 18, 2025: An implant called TAR-200 has shown remarkable results in treating high-risk bladder cancer. According to a recent Phase.

Read More
Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved by the FDA for people between 18 and 65 years.
Health Medical

Medical journal refuses to retract vaccine study as demanded by US health secretary

HQ Team August 14, 2025: The Annals of Internal Medicine has refused to retract a recent study that refuted any connection between aluminum.

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Health Research

Researchers identify natural alternative to Ozempic: Promising weight loss option

HQ Team August 12, 2025: Researchers from Jiangnan University in China have discovered a potential natural alternative to Ozempic, a popular GLP-1 receptor.

Read More
Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to cancer spreading faster, according to a study by researchers at the University of Copenhagen.
Drugs Health

New pancreatic cancer vaccine shows promise in preventing recurrence in trial-1

HQ Team August 12, 2025: A new study published in the journal Nature Medicine has shown promising results for an experimental vaccine, ELI-002.

Read More
The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due to the potential risk of infections.
Health

FDA approves VIZZ eye drops: A new option for presbyopia

HQ Team August 11, 2025: The US Food and Drug Administration (FDA) has granted approval to VIZZ (aceclidine ophthalmic solution 1.44%), an innovative.

Read More
About 67 million people globally living with chronic fatigue syndrome have different genes compared to their healthy counterparts, initial findings from the world's largest research study on the illness reveal.
Health Pharma Research

UK researchers unravel 8 gene variants in chronic fatigue syndrome 

About 67 million people globally living with chronic fatigue syndrome have different genes compared to their healthy counterparts, initial findings from the world's.

Read More
Jazz Pharmaceuticals Plc’s treatment for a rare and aggressive brain tumour that affects children and adults got approval from the US regulator.
Drugs Health Pharma

Jazz Pharma’s oral drug for a type of brain tumour gets US approval 

Jazz Pharmaceuticals Plc’s treatment for a rare and aggressive brain tumour that affects children and adults got approval from the US regulator.

Read More
Hanuman complex is very much implied in positive psychology in this sense. It helps individuals to rediscover their hidden potential. Rooted in Hanuman’s journey, literally across the sea of emotions, self-doubt and diffidence, it reminds us that when people are seen, heard and believed in, they fly.
Health Medical Opinion

Hanuman Complex: An Indian take on positive psychology and its human effect

Hanuman complex is very much implied in positive psychology in this sense. It helps individuals to rediscover their hidden potential. Rooted in Hanuman’s.

Read More
The Gates Foundation will support more than 40 innovations in five chronically underfunded areas in women’s health by spending $2.5 billion over the next five years.
Drugs Health Pharma

Gates Foundation to spend $2.5 billion on women’s health innovations

The Gates Foundation will support more than 40 innovations in five chronically underfunded areas in women’s health by spending $2.5 billion over the.

Read More